Table 1.
Study | Sample sizea | Women (%) | Age (years) | Adherence (yes/no) | Attrition (%) | Outcome endpoint (week)b | ITT analysis (yes/no) | Duration (weeks) | Treatment | |
---|---|---|---|---|---|---|---|---|---|---|
Dosage (sessions) | Format | |||||||||
Keller et al. (2000) | 681 | 65.3 | 43 | Yes | 24.3 | 12 | Yes | 12 | 16 | Individual |
Kocsis et al. (2009) | 491 | 55.4 | 44.5 | Yes | 13.8 | 12 | – | 12 | 12.5 | Individual |
Schramm et al. (2011a) | 30 | 55 | 40.2 | Yes | 10 | 16 | Yes | 16 | 22 | Individual |
Wiersma et al. (2014) | 142 | 60 | 41.5 | Yes | 25 | 52 | Yes | 52 | 25.1 | Individual |
Schramm et al. (2015) | 60 | 54 | 43.6 | Yes | 19 | 32 | Yes | 36 | 22 | Individual |
Michalak et al. (2015) | 106 | 62.3 | 50.9 | Yes | 28.2 | 8 | Yes | 10 | 6–10c | Group |
ITT, intention‐to‐treat; CBASP, cognitive behavioral analysis system of psychotherapy.
Overall sample size of participants randomized to treatment and control conditions.
To aggregate effect sizes across studies, this primary outcome endpoint was used.
Two initial sessions were conducted individually. –: insufficient information provided.